Limits...
Repetitive transcranial magnetic stimulation in cervical dystonia: effect of site and repetition in a randomized pilot trial.

Pirio Richardson S, Tinaz S, Chen R - PLoS ONE (2015)

Bottom Line: ClinicalTrials.gov NCT01859247.

View Article: PubMed Central - PubMed

Affiliation: Department of Neurology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.

ABSTRACT

Trial registration: ClinicalTrials.gov NCT01859247.

No MeSH data available.


Change in TWSTRS severity score as a function of time shown from Session 1 to Session 5.Individual subject data shown as well as study group mean data shown in blue line. Red line represents historical control data from Comella et al., 2011 [14] showing similar severity scores at Week 8 post-botulinum toxin injection (study Session 1). *p = 0.01.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4414555&req=5

pone.0124937.g004: Change in TWSTRS severity score as a function of time shown from Session 1 to Session 5.Individual subject data shown as well as study group mean data shown in blue line. Red line represents historical control data from Comella et al., 2011 [14] showing similar severity scores at Week 8 post-botulinum toxin injection (study Session 1). *p = 0.01.

Mentions: A one-sample Wilcoxon signed rank test of the averaged TWSTRS severity score from Session 1 to Session 5 compared to the historical control change from 8 weeks to 12 weeks-post injection revealed a significant difference between the improvement seen in our study compared to the wane of the clinical benefit of botulinum toxin over that 4 week interval (p = 0.008) (Fig 4).


Repetitive transcranial magnetic stimulation in cervical dystonia: effect of site and repetition in a randomized pilot trial.

Pirio Richardson S, Tinaz S, Chen R - PLoS ONE (2015)

Change in TWSTRS severity score as a function of time shown from Session 1 to Session 5.Individual subject data shown as well as study group mean data shown in blue line. Red line represents historical control data from Comella et al., 2011 [14] showing similar severity scores at Week 8 post-botulinum toxin injection (study Session 1). *p = 0.01.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4414555&req=5

pone.0124937.g004: Change in TWSTRS severity score as a function of time shown from Session 1 to Session 5.Individual subject data shown as well as study group mean data shown in blue line. Red line represents historical control data from Comella et al., 2011 [14] showing similar severity scores at Week 8 post-botulinum toxin injection (study Session 1). *p = 0.01.
Mentions: A one-sample Wilcoxon signed rank test of the averaged TWSTRS severity score from Session 1 to Session 5 compared to the historical control change from 8 weeks to 12 weeks-post injection revealed a significant difference between the improvement seen in our study compared to the wane of the clinical benefit of botulinum toxin over that 4 week interval (p = 0.008) (Fig 4).

Bottom Line: ClinicalTrials.gov NCT01859247.

View Article: PubMed Central - PubMed

Affiliation: Department of Neurology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.

ABSTRACT

Trial registration: ClinicalTrials.gov NCT01859247.

No MeSH data available.